Mycobacteria Flashcards

1
Q

What is the main acid-fast genus of bacteria?

A

Mycobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the gram stain of mycobacteria?

A

gram +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the O2 requirements of mycobacteria?

A

Obligate aerobe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Koch identified ________ as cause of TB in 1882:•Humans are reservoir•airborne transmission (as few as 10 cells can result in infection)

A

Mycobacterium tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Koch identified Mycobacterium tuberculosis as cause of TB in 1882:• ______ are reservoir
•airborne transmission (as few as 10 cells can result in infection)

A

Humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Koch identified Mycobacterium tuberculosis as cause of TB in 1882:
• Humans are reservoir
•______ transmission (as few as 10 cells can result in infection)

A

airborne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mycolic acids in cell wall
Gram+weak staining: use acid-fast stain or specific fluorescent detection
Facultative intracellular growth(in macrophages)
Obligate aerobe (growth in lung macrophages)

A

Mycobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What stain is used to distinguish mycobacteria

A

Acid fast stain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the chemical composition of the cord factor within the mycobacterial cell wall?

A

glyco-lipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Slow, cord-like growth
strongly correlates
with virulence.

Cord-like growth results from adherence of cell surface lipid mycolic acids and glyco-lipids

A

virulence factors of mycobacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

While many “virulence factors” are listed, their virulence results from the challenge that they provide to the _____ _____ (typically DTH: CD4+ T-cells + macrophages)
because (in most cases) the disease is caused by the immune response, NOT by the mycobacteria.

A

immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Facultative intracellular growth in alveolar and other macrophages:
inhibition of phago-lysosome fusion

A

virulence factor of M.tuberculosis and M.leprae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_______ _______ is a “life-long” pathogen: once infected, you may be asymptomatic but never cured.

A

Mycobacterium tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

the _____ area of the necrosis is where the ______ have been destroyed.

A

central

nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Effective CMI is capable of localizing and stopping infection by M.tuberculosis. Chronic TB is
typical.

What is the exception????

A

Exception: young children under 5 years have a high risk for developing progressive TB due
to insufficient immune system development/activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • 91% no disease
  • 6% clinical TB (2% pulmonary + 3% extrathoracic + 1% both)
  • 3% progressive systemic disease and death.
A

OUTCOMES of untreated primary TB [results for non-immune-compromised patents]:

17
Q

However, ______ (‘open’) TB [also known as “secondary tuberculosis” or in older terms
“galloping consumption” caused by “endogenous reactivation” of prior infection

  • while rare (life-time risk is assessed as <12% for carriers, or less) it is VERY contagious!
    Isolation of acute TB cases is mandatory. Endogenous reactivation is stimulated by stress, malnutrition and HIV
18
Q

T/f: concerning Mycobacterium tuberculosis, the “disease” (except for the infection risk of “Open TB”) arises from tissue destruction
by our immune defenses and not by damage caused by the bacterial infection.

19
Q

t/f: The repeated attempts to remove foci of infection by lung macrophages cause the granulomatous
lung tissue that impairs lung function.

20
Q

t/f: Breathing impairment in TB is not due to tuberculosis bacilli but by the macrophage-induced tissue
destruction

21
Q

A positive tuberculin test to subdermal PPD (processed protein derivative of the cell wall of the opportunistic intracellular pathogen M ycobacterial tuberculosis).

A

Mantoux Reaction

22
Q

with the Mantoux Reaction test, a >10mm redness indicates _______ while a >20 mm redness indicates ______.

A

positive test

strong positive

23
Q

Exposure to living attenuated mycobacterium, known as Bacille Calmette-Guérin (BCG), a derivative of M.bovis (which may be identical to M.tuberculosis based on whole genome sequencing):

  • little virulence in humans (but infectious in immune-compromised persons)
  • some protective immunity (when given to young children)
  • BCG vaccination is discouraged in USA because it gives a positive tuberculin test, thus removing an important diagnostic screening tool. (And M.bovis causes disease in immune-compromised persons.)
A

m. tuberculosis vaccine

24
Q

macrophages kill nerves; macules and plaques without sensation

Good prognosis for recovery NOT infectious

A

Th1-response

25
Q

Bad prognosis for recovery Highly infectious

Loss of CMI (CTL lysis and loss of tissue including nerves)

A

Th 2-response

26
Q

Dapsone + rifampin + clofazimine

Rising resistance is becoming a problem.

A

Multi-drug therapy

27
Q

virulence factor of ____ ____

ability to survive and live in lung macrophages

A

m. Tuberculosis

28
Q

clinical factor of ____ _____:

pulmonary and extrapulmonary tuberculosis.

A

m. Tuberculosis

29
Q

treatment of _____ ____:

multidrug therapy (6-12 months)

A

m. Tuberculosis

30
Q

epidemiology of ____ ____:

aerosol (person to person)
all ages
highest risk if : immune compromised (HIV)

A

m. Tuberculosis

31
Q

virulence factor of ____ ____

ability to survive and live in macrophages

32
Q

clinical factor of ____ _____:

tuberculoid to lepramatous leprosy

33
Q

treatment of _____ ____:

multidrug therapy (2 years)

34
Q

epidemiology of ____ ____:

close physical contact

35
Q

t/f: All pathogenic mycobacterial species have (very) slow growth rates

36
Q

Gram+ (poor staining)

• mycolic acid in cell wall: “partially acid-fast”
(Test to distinguish Nocardia from fungal look-alikes)

Opportunistic pathogen
in immuno-compromised patients